Publication | Open Access

Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity

ThrombosisCardiovascular DiseaseBlood PlateletMedicineHematologyHemostasisDose-dependent Antithrombotic ActivityPharmacotherapyCoagulopathyPlatelet AntagonistPharmacologyAnticoagulantAtherosclerosisConcomitant Enhancement